Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

07-10

InnoModels Biotechnology PDC High-Throughput In Vitro Drug Efficacy Platform: Introduction of Technical Advantages

In the field of drug discovery and development, an efficient and accurate drug efficacy evaluation platform plays a crucial role in the successful development and clinical application of new drugs. With its unique technology and advantages, InnoModels' PDC high-throughput in vitro drug efficacy platform provides unprecedented accuracy and reliability for drug R&D and clinical treatment, and has become an important force leading the field of drug evaluation.

07-09

InnoModels Biotechnology ADCC platform: what are the key features

With the rapid development of the biopharmaceutical field, the importance of antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism in tumor immunotherapy has become increasingly prominent. In order to meet the growing research needs, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully built an in vitro pharmacodynamics platform, of which the ADCC platform has been widely recognized by the industry for its unique features and advantages. This article will introduce the main features of ADCC platform.

07-08

What is unique about the InnoModels Biotechnology CDX platform?

In the vast field of biomedical research and clinical treatment, the innovation and development of modeling platforms are crucial for advancing scientific research, accelerating the development of new drugs, and realizing personalized treatment. Against this backdrop, InnoModels Biotechnology (Beijing) Co., Ltd. has become a leader in the industry with its unique CDX (Cancer-Derived Xenograft) platform. In this article, we will discuss the unique features of the CDX platform and how it provides strong support for cancer research and clinical treatment.

07-05

InnoModels Biotechnology: Immunogenicity Testing Platform for New Drug Development

In the field of biopharmaceuticals, immunogenicity testing is an important part of the drug development process. With the rapid development of biopharmaceutical technology, there is an increasing demand for drug immunogenicity assessment. In order to meet this demand, InnoModels Biotechnology (Beijing) Co., Ltd. has launched an immunogenicity testing platform with significant advantages by virtue of its excellent technical strength. In this article, we will introduce the features of InnoModels' immunogenicity testing platform and its important role in new drug development.

< 1...13 14 15...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License